Başoğlu M, Marks I M, Kiliç C, Swinson R P, Noshirvani H, Kuch K, O'Sullivan G
Institute of Psychiatry, Denmark Hill, London.
Br J Psychiatry. 1994 May;164(5):647-52. doi: 10.1192/bjp.164.5.647.
In a controlled trial of alprazolam and exposure in 154 patients with panic disorder with agoraphobia, relations between panic, anticipatory anxiety, and phobic avoidance were examined. The three symptoms were independent of one another at baseline and improved largely independently during treatment; only early improvement in avoidance predicted global improvement after treatment. Global improvement was more related to reduction of avoidance than a decrease in panics. Panic was not a valuable outcome measure in panic disorder with agoraphobia.
在一项针对154名伴有广场恐惧症的惊恐障碍患者的阿普唑仑与暴露对照试验中,研究了惊恐、预期焦虑和恐惧回避之间的关系。这三种症状在基线时相互独立,且在治疗期间大多独立改善;只有回避症状的早期改善能预测治疗后的整体改善情况。整体改善与回避症状的减轻比与惊恐发作次数的减少更相关。在伴有广场恐惧症的惊恐障碍中,惊恐发作并非一个有价值的疗效指标。